03:27 AM EDT, 09/12/2025 (MT Newswires) -- Mahkam Zanganeh, 10% Owner, Director, Co-Chief Executive Officer, on September 10, 2025, executed a purchase for 338,394 shares in Summit Therapeutics ( SMMT ) for $5,984,756. Following the Form 4 filing with the SEC, Zanganeh has control over a total of 591,831,532 common shares of the company, with 31,000 shares held directly and...

03:25 AM EDT, 09/12/2025 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & Chief Executive Officer, on September 10, 2025, sold 8,000 shares in United Therapeutics ( UTHR ) for $3,183,777. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 644,489 common shares of the company, with 130 shares held directly and 644,359 controlled...

03:29 AM EDT, 09/12/2025 (MT Newswires) -- Evan L Russo, Chief Executive Officer of Asset Management, on September 09, 2025, sold 75,000 shares in Lazard ( LAZ ) for $4,240,260. Following the Form 4 filing with the SEC, Russo has control over a total of 227,915 common shares of the company, with 227,915 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1311370/000171748925000003/xslF345X05/wk-form4_1757633247.xml ...

03:28 AM EDT, 09/12/2025 (MT Newswires) -- Robert W Duggan, 10% Owner, Director, Co-Chief Executive Officer, on September 10, 2025, executed a purchase for 338,394 shares in Summit Therapeutics ( SMMT ) for $5,984,756. Following the Form 4 filing with the SEC, Duggan has control over a total of 591,831,532 common shares of the company, with 556,093,090 shares held directly...